[Therapy of acute experimental pancreatitis with the antifibrinolytic drug PAMBA (author's transl)].
In acute experimental pancreatitis in the rat neither intravenous nor intramuscular therapy with the antifibrinolytic drug PAMBA (p-aminomethylbenzoic-acid) had any influence on the lethality, enzyme content in either serum, ascites and pancreas or on the amount of destruction of the organ.
D000208:Acute Disease; D000818:Animals; D001565:Benzoates / Q000008:administration & dosage / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004285:Dogs; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008744:Methylamines / Q000008:administration & dosage / Q000627:therapeutic use; D010195:Pancreatitis / Q000188:drug therapy*; D062366:para-Aminobenzoates
D001565:Benzoates; D008744:Methylamines; D062366:para-Aminobenzoates; C015668:4-aminomethylbenzoic acid
Therapie der akuten experimentellen Pankreatitis mit dem Antifibrinolytikum PAMBA.